{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:57:19Z","timestamp":1792688239513,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21S11907100"],"award-info":[{"award-number":["21S11907100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172615"],"award-info":[{"award-number":["82172615"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jconrel.2022.02.020","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T22:07:41Z","timestamp":1645049261000},"page":"62-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy"],"prefix":"10.1016","volume":"344","author":[{"given":"Andy Samuel","family":"Widjaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jconrel.2022.02.020_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s40820-020-00482-6","article-title":"A review on Nano-based drug delivery system for Cancer Chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2022.02.020_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2020.07.007","article-title":"Delivering the power of nanomedicine to patients today","volume":"326","author":"Germain","year":"2020","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2022.02.020_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/nnm-2019-0308","article-title":"Updates on the use of liposomes for active tumor targeting in cancer therapy","volume":"15","author":"Yan","year":"2020","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0030","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J Contr. Release"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fbioe.2019.00415","article-title":"Overcoming physiological barriers to nanoparticle delivery-are we there yet?","volume":"7","author":"Thomas","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2019.10.021","article-title":"Personal perspectives and concerns over the so-called nanomedicine","volume":"311-312","author":"Yang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119578","article-title":"Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia","volume":"228","author":"Sahu","year":"2020","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.jconrel.2022.02.020_bb0050","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3892\/ol.2013.1591","article-title":"Corosolic acid enhances the antitumor effects of chemotherapy on epithelial ovarian cancer by inhibiting signal transducer and activator of transcription 3 signaling","volume":"6","author":"Fujiwara","year":"2013","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2022.02.020_bb0055","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/mnfr.201200610","article-title":"Corosolic acid impairs tumor development and lung metastasis by inhibiting the immunosuppressive activity of myeloid-derived suppressor cells","volume":"57","author":"Horlad","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"issue":"5","key":"10.1016\/j.jconrel.2022.02.020_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126725","article-title":"Corosolic acid inhibits hepatocellular carcinoma cell migration by targeting the VEGFR2\/Src\/FAK pathway","volume":"10","author":"Ku","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jconrel.2022.02.020_bb0065","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.3892\/mmr.2015.3982","article-title":"Corosolic acid enhances 5-fluorouracil-induced apoptosis against SNU-620 human gastric carcinoma cells by inhibition of mammalian target of rapamycin","volume":"12","author":"Lee","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.actbio.2020.02.013","article-title":"Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs","volume":"106","author":"Li","year":"2020","journal-title":"Acta Biomater."},{"issue":"24","key":"10.1016\/j.jconrel.2022.02.020_bb0075","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.3390\/molecules25245986","article-title":"A compressive review about Taxol(R): history and future challenges","volume":"25","author":"Gallego-Jara","year":"2020","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jconrel.2022.02.020_bb0080","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3390\/cancers11121855","article-title":"Thirty years of cancer nanomedicine: success, frustration, and hope","volume":"11","author":"Salvioni","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.jconrel.2022.02.020_bb0085","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1021\/acs.molpharmaceut.9b00329","article-title":"Paclitaxel-loaded folate-coated pH-sensitive liposomes enhance cellular uptake and antitumor activity","volume":"16","author":"Monteiro","year":"2019","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2022.02.020_bb0090","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1021\/acs.molpharmaceut.8b01123","article-title":"Cell permeable NBD peptide-modified liposomes by hyaluronic acid coating for the synergistic targeted therapy of metastatic inflammatory breast cancer","volume":"16","author":"Sun","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomaterials.2017.09.013","article-title":"pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells","volume":"147","author":"Yang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0100","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1073\/pnas.0809784106","article-title":"Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB","volume":"106","author":"Porta","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0105","article-title":"On-demand autophagy cascade amplification nanoparticles precisely enhanced oxaliplatin-induced cancer immunotherapy","volume":"32","author":"Wang","year":"2020","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2022.02.020_bb0110","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/acs.nanolett.9b03883","article-title":"Self-delivery micellar nanoparticles prevent Premetastatic niche formation by interfering with the early recruitment and vascular destruction of granulocytic myeloid-derived suppressor cells","volume":"20","author":"Long","year":"2020","journal-title":"Nano Lett."},{"issue":"13","key":"10.1016\/j.jconrel.2022.02.020_bb0115","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/glia.20863","article-title":"Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice","volume":"57","author":"Zhang","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2018.02.006","article-title":"Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy","volume":"153","author":"Radogna","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119902","article-title":"Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: the current status and transcytosis strategy","volume":"240","author":"Zhou","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152933","article-title":"Novel targets of pentacyclic triterpenoids in Staphylococcus aureus: a systematic review","volume":"73","author":"Chung","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2015.01.015","article-title":"Pentacyclic triterpene derivatives possessing polyhydroxyl ring a inhibit gram-positive bacteria growth by regulating metabolism and virulence genes expression","volume":"95","author":"Huang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jconrel.2022.02.020_bb0140","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/molecules21070884","article-title":"The pleiotropic antibacterial mechanisms of Ursolic acid against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"21","author":"Wang","year":"2016","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jconrel.2022.02.020_bb0145","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1128\/AAC.01037-06","article-title":"Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin","volume":"51","author":"Garo","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.jconrel.2022.02.020_bb0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/0971-5916.156631","article-title":"Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli","volume":"141","author":"Wojnicz","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-pathol-020117-044127","article-title":"Cancer metastasis: a reappraisal of its underlying mechanisms and their relevance to treatment","volume":"13","author":"Riggi","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"11","key":"10.1016\/j.jconrel.2022.02.020_bb0160","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","article-title":"Tumor metastasis: moving new biological insights into the clinic","volume":"19","author":"Wan","year":"2013","journal-title":"Nat. Med."},{"issue":"40","key":"10.1016\/j.jconrel.2022.02.020_bb0165","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.2174\/1381612825666190215121712","article-title":"Oxidative stress and cancer","volume":"24","author":"Klaunig","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.jconrel.2022.02.020_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054125","article-title":"ATP mediates NADPH oxidase\/ROS generation and COX-2\/PGE2 expression in A549 cells: role of P2 receptor-dependent STAT3 activation","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jconrel.2022.02.020_bb0175","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/cdd.2012.89","article-title":"Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis","volume":"19","author":"Nikulenkov","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0180","doi-asserted-by":"crossref","first-page":"4350965","DOI":"10.1155\/2016\/4350965","article-title":"ROS and ROS-mediated cellular signaling","volume":"2016","author":"Zhang","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.jconrel.2022.02.020_bb0185","first-page":"8289","article-title":"Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT\/MAPK signaling pathway in canine mammary gland tumor cells","volume":"17","author":"Ren","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5604\/17322693.1150133","article-title":"Different pathways of macrophage activation and polarization","volume":"69","author":"Juhas","year":"2015","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"issue":"3","key":"10.1016\/j.jconrel.2022.02.020_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.08.010","article-title":"An NF-kappaB transcription-factor-dependent lineage-specific transcriptional program promotes regulatory T cell identity and function","volume":"47","author":"Oh","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jconrel.2022.02.020_bb0200","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","article-title":"IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo","volume":"108","author":"Zorn","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.02.020_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-kappaB in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2022.02.020_bb0210","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2022.02.020_bb0215","doi-asserted-by":"crossref","first-page":"14655","DOI":"10.1038\/s41598-017-14709-x","article-title":"Precision targeting of tumor macrophages with a CD206 binding peptide","volume":"7","author":"Scodeller","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2022.02.020_bb0220","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.jconrel.2022.02.020_bb0225","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","article-title":"Paclitaxel induces immunogenic cell death in ovarian Cancer via TLR4\/IKK2\/SNARE-dependent exocytosis","volume":"8","author":"Lau","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2022.02.020_bb0230","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13402-020-00544-2","article-title":"Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression","volume":"43","author":"Li","year":"2020","journal-title":"Cell. Oncol (Dordr)."},{"issue":"6","key":"10.1016\/j.jconrel.2022.02.020_bb0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s13402-020-00552-2","article-title":"Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy","volume":"43","author":"Zhu","year":"2020","journal-title":"Cell. Oncol (Dordr)."},{"issue":"2","key":"10.1016\/j.jconrel.2022.02.020_bb0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cell.2016.05.051","article-title":"Autophagy, inflammation, and immunity: a troika governing cancer and its treatment","volume":"166","author":"Zhong","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2022.02.020_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2022.02.020_bb0250","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1158\/1078-0432.CCR-11-0816","article-title":"Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation","volume":"17","author":"Ding","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.jconrel.2022.02.020_bb0255","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.jconrel.2022.02.020_bb0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40199-020-00326-z","article-title":"STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells","volume":"28","author":"Jafari","year":"2020","journal-title":"Daru"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:15:57Z","timestamp":1759162557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922000943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":52,"alternative-id":["S0168365922000943"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}